Investors are looking ahead to where the money can be made in Q2. Les Funtleyder, Poliwogg health care strategist and Doug Sandler, Riverfront Investment Group, provide perspective.

Florida Republican Senator Marco Rubio has joined the filibuster threat over the pending gun control legislation, with Robert Costa of the National Review. Also, Rep. Peter Roskam (R-IL); Dean Baker Center For Economic & Policy Research; and Hadley Heath, Independent Women's Forum, discuss whether Republicans can overturn Obamacare.

There are a lot of forgeries out there and it can be very difficult to tell the difference between what's real and what isn't. The chances of finding something that is ancient are about as good as finding a needle in a haystack, but if found, it can be worth a fortune. Curtis Dowling, from CNBC's "Treasure Detectives," explains what you can do to help determine whether or not a piece of pottery is a fake.

Eric Sprott, CEO at Sprott Asset Management explains why promises of money printing by the Bank of Japan's new leadership isn't enough reason to buy Japanese stocks.

Following the S&P's record run, a warning sign for stocks. The market's next move, with Mark Dow, Behavioral Macro Blog, CNBC's Jackie DeAngelis and the Futures Now Traders.

Q2 beings Monday, so which stocks should you get in? Chad Morganlander, Stifel Nicolaus; Sandy Villere, Villere & Co.; and Chad Deakins, Ridgeworth Capital Management, weigh in.

Cramer shares six stocks to watch, and reveals them in under 60 seconds. Today, Tumi, Zillow, US Airways, Kraft, Micron and Dollar General.

From the pits, the "Futures Now" traders explain what's putting downward pressure on the yellow metal, with Euro Pacific's Peter Schiff, CNBC's Jackie DeAngelis and the Futures Now Traders.

Robert Gamgort, Pinnacle Foods CEO, weighs in on the company's IPO today.

CNBC's Seema Mody takes a look at how the S&P 500 and the Dow have performed since the lows of March in 2009; and Edward Yardeni of Yardeni Research and Michael Ozanian of Forbes Magazine, weigh in.

The Futures Now team discusses what the markets have in store for the precious metal.

Mad Money host Jim Cramer dissects the market's latest action, and what market events to look out for in the first week of Q2.

Leaders in stock market gains by health care or consumer staples shouldn't be discounted, Chris Verrone of Strategas says.

One technical analyst and one fundamental analyst disagree on whether to buy the Dow stock that has had the worst price performance year-to-date. (2:39)

CNBC's Melissa Lee and the Fast Money traders discuss the day's top trades and the stocks they'll be watching tomorrow.

Shares of eBay are up nearly 4 percent as the company works to expand globally. eBay CEO John Donahoe, discusses how much future growth will come from mobile and social media, and also international growth.

Mad Money host and former hedge fund manager, Jim Cramer, provides stock traders with all manner of investing advice.

An all-time closing high in the S&P 500 wasn't enough to turn Shelter Harbor Capital's Brian Kelly away from his bearish theme.

Inventing new drugs can be a fabulous growth business, but biotech stocks represent the future of pharma, explains Mad Money host Jim Cramer. A look at Regeneron Pharmaceuticals.

The FMHR traders weigh in on the S&P's surge higher today. Meanwhile Laszlo Birinyi, Birinyi Associates, says investors should look at specific stocks instead of broad sectors.